Through a decline in use of Hormone Therapies
Since the summer of 2002 American women have clearly taken fewer hormone replacement therapies. And some months later the rate of breast cancer patients began to sink in a conspicuous manner. A statistical evaluation drawn up by a team [working] with Peter Ravdin at the University of Texas emphasized this connection.
Between 1990 and 1998 the rate of breast cancer cases had regularly increased about 1.7 percent per year. The following years it regularly decreased about 1 percent per year. Then however the curve suddenly takes a sharp kink. In 2003 12 percent fewer American women fell ill with breast cancer than in the previous year.
The researchers found out that particularly women between 50 and 69 years of age were responsible for this very gratifying result. In addition, especially those cancer types whose growth is accelerated by estrogens and gestagen were affected. Both [results] suggest very much to the scientists the conclusion that a connection exists between the heavy decrease of hormone therapies since the summer of 2002 and the sinking number of breast cancer patients.
In the summer of 2002 it became publicly known that hormone therapies can increase the risk of breast cancer. This was revealed by a study of 16,000 women which was broken off prematurely due to the alarming results.